DECISION OF THE EEA JOINT COMMITTEE No 235/2023

of 22 September 2023

amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement [2024/1009]

THE EEA JOINT COMMITTEE,

Having regard to the Agreement on the European Economic Area (“the EEA Agreement”), and in particular Article 98 thereof,

Whereas:

(1) Commission Implementing Decision (EU) 2023/458 of 1 March 2023 on the non-approval of certain active substances for use in biocidal products in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council ( 1 ) is to be incorporated into the EEA Agreement.

(2) Commission Implementing Decision (EU) 2023/459 of 2 March 2023 not approving 2,2-Dibromo-2-cyanoacetamide (DBNPA) as an existing active substance for use in biocidal products of product-type 4 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council ( 2 ) is to be incorporated into the EEA Agreement.

(3) Commission Implementing Decision (EU) 2023/460 of 2 March 2023 postponing the expiry date of the approval of imidacloprid for use in biocidal products of product-type 18 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council ( 3 ) is to be incorporated into the EEA Agreement.

(4) Annex II to the EEA Agreement should therefore be amended accordingly,

HAS ADOPTED THIS DECISION:

Article 1

The following points are inserted after point 12zzzzzzzzz (Commission Implementing Regulation (EU) 2022/1991) of Chapter XV of Annex II to the EEA Agreement:

‘12zzzzzzzzza.

32023 D 0458 : Commission Implementing Decision (EU) 2023/458 of 1 March 2023 on the non-approval of certain active substances for use in biocidal products in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council ( OJ L 67, 3.3.2023, p. 51 ).

12zzzzzzzzzb.

32023 D 0459 : Commission Implementing Decision (EU) 2023/459 of 2 March 2023 not approving 2,2-Dibromo-2-cyanoacetamide (DBNPA) as an existing active substance for use in biocidal products of product-type 4 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council ( OJ L 67, 3.3.2023, p. 54 ).

12zzzzzzzzzc.

32023 D 0460 : Commission Implementing Decision (EU) 2023/460 of 2 March 2023 postponing the expiry date of the approval of imidacloprid for use in biocidal products of product-type 18 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council ( OJ L 67, 3.3.2023, p. 58 ).’

Article 2

The texts of Implementing Decisions (EU) 2023/458, (EU) 2023/459 and (EU) 2023/460 in the Icelandic and Norwegian languages, to be published in the EEA Supplement to the Official Journal of the European Union , shall be authentic.

Article 3

This Decision shall enter into force on 23 September 2023, provided that all the notifications under Article 103(1) of the EEA Agreement have been made ( *1 ) .

Article 4

This Decision shall be published in the EEA Section of, and in the EEA Supplement to, the Official Journal of the European Union .

Done at Brussels, 22 September 2023.

For the EEA Joint Committee

The President

Pascal SCHAFHAUSER

( 1 ) OJ L 67, 3.3.2023, p. 51 .

( 2 ) OJ L 67, 3.3.2023, p. 54 .

( 3 ) OJ L 67, 3.3.2023, p. 58 .

( *1 ) No constitutional requirements indicated.

ELI: http://data.europa.eu/eli/dec/2024/1009/oj

ISSN 1977-0677 (electronic edition)